Option Care Health Inc Stock Price, News & Analysis

Option Care Health (Nasdaq: OPCH) reported strong financial results for Q1 2021, with net revenue of $759.2 million, an increase of 7.6% from the previous year. Gross profit rose to $165.5 million, representing 21.8% of net revenue. The net loss narrowed to $2.9 million, or $0.02 per share, improving from a loss of $19.9 million in Q1 2020. Adjusted EBITDA surged 30% to $52.2 million. The company also announced the retirement of its second lien debt and an acquisition of chronic therapy assets for $18.5 million.

Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., will present at the Bank of America 2021 Health Care Conference on May 11, 2021, at 8:45 a.m. EDT. CEO John Rademacher and CFO Mike Shapiro are scheduled to represent the company during this event. With over 5,000 employees, including around 2,900 clinicians, Option Care Health focuses on enhancing care standards for patients with both acute and chronic conditions across all 50 states.

Option Care Health (NASDAQ: OPCH) announced its first-quarter earnings report will be released on May 6, 2021, before market opening. The management team will host a conference call at 8:30 a.m. E.T. to discuss the results. Option Care Health is the largest independent provider of home and alternate site infusion services in the U.S., employing over 5,000 individuals, including about 2,900 clinicians. The company aims to enhance care standards for patients with both acute and chronic conditions across all 50 states.

Option Care Health announced that an affiliate of Madison Dearborn Partners will sell 12,000,000 shares of its common stock at $20.00 per share in an underwritten public offering. This represents approximately 6.7% of shares outstanding, which may increase to 7.7% if the underwriter's option for an additional 1,800,000 shares is exercised. The sale is expected to close on March 17, 2021, with Goldman Sachs acting as the underwriter. Option Care will not receive any proceeds from this offering, and the Selling Stockholder's ownership will decrease from 54.0% to 47.3%.

Option Care Health announced the sale of 12 million shares of its common stock by Madison Dearborn Partners, representing approximately 6.7% of the total shares outstanding. The underwritten public offering includes a 30-day option for the underwriter to purchase an additional 1.8 million shares. After this sale, Madison Dearborn's ownership will decrease from 54% to 47.3%. The company will not receive any proceeds from this offering, and the sole underwriter is Goldman Sachs & Co. LLC.

Option Care Health (Nasdaq: OPCH) reported strong financial results for Q4 and full year 2020. Net revenue for Q4 reached $804.7 million, marking an 11.6% increase year-over-year. Full year net revenue was $3.032 billion, up 31.3%. The company achieved a net income of $17.8 million or $0.10 EPS, compared to a loss in the previous year. Adjusted EBITDA rose 69.5% to $221.7 million. Full year guidance for 2021 predicts revenue between $3.20 billion and $3.25 billion.

Option Care Health announced a public offering of 15,000,000 shares at $18.50 each, up from a previously planned 10,000,000 shares. The underwriter, Goldman Sachs, has a 30-day option to purchase an additional 2,250,000 shares. The offering will close on February 10, 2021. The sale will decrease the Selling Stockholder's interest in the Company from 63.6% to 55.2%. The Company will not receive any proceeds from this offering, which accounts for approximately 8.3% of the outstanding shares, or 9.6% with full exercise of the underwriter's option.

Option Care Health (NASDAQ: OPCH) announced the sale of 10,000,000 shares of its common stock by an affiliate of Madison Dearborn Partners in an underwritten public offering. This sale represents approximately 5.6% of shares outstanding and could increase to 6.4% with an additional 1,500,000 shares option. Post-offering, the Selling Stockholder's ownership will reduce from 63.6% to 58.0%. The offering is managed by Goldman Sachs & Co. LLC, and the Company will not receive any proceeds from the sale.

Option Care Health (NASDAQ: OPCH) announced preliminary financial results for Q4 and the fiscal year ending December 31, 2020. For Q4, net revenue is expected to be between $800 million to $805 million, an 11% growth year-over-year. Net income is projected at $16 million to $18 million, with adjusted EBITDA between $66 million to $68 million, reflecting a 25% to 28% increase. For FY 2020, net revenue is projected at approximately $3.03 billion, but a net loss is anticipated between $7.9 million to $9.9 million.